Disciplined Investments, LLC Catalent, Inc. Transaction History

Disciplined Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$31.86 - $67.26 $159 - $336	-5 Reduced 33.33%	10 $0
Q1 2023 May 10, 2023	BUY	$45.44 - $74.26 $136 - $222	3 Added 25.0%	15 $0
Q4 2022 Feb 01, 2023	BUY	$41.39 - $81.0 $248 - $486	6 Added 100.0%	12 $0
Q3 2022 Nov 03, 2022	SELL	$72.36 - $113.1 $723 - $1,131	-10 Reduced 62.5%	6 $0
Q2 2022 Aug 09, 2022	BUY	$87.2 - $114.05 $348 - $456	4 Added 33.33%	16 $2,000
Q1 2022 Apr 22, 2022	BUY	$94.19 - $124.49 $1,130 - $1,493	12 New	12 $1,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplined Investments, LLC with notifications on news.